Summit shares jumped Monday after positive late-stage indications vs. Merck’s Keytruda. The biotech stock rallied 30%.
Did This Lung Cancer Treatment Just Outflank Merck’s Keytruda?
Related Posts
Enlarge / NASA officials inside SpaceX's launch control center at Hangar X watch the liftoff of a Falcon 9 rocket a few miles away on March 3, 2024. (credit: NASA/Aubrey
Enlarge (credit: Vlatko Gasparic via Getty Images) OpenAI finally unveiled its rumored "Strawberry" AI language model on Thursday, claiming significant improvements in what it calls "reasoning" and problem-solving capabilities over
Enlarge / Cutting metal with lasers is hard, but even harder when you don't know the worst-case timings of your code. (credit: Getty Images) As is so often the case,
Enlarge / A rendering of NASA's Lunar Gateway. (credit: NASA) Regardless of the outcome of this year’s election, the United States will have a new president in a few months.